Capital Planning LLC Amgen Inc Transaction History

Capital Planning LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $179,568 - $202,520	-800 Reduced 26.4%	2,230 $503,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $153,137 - $175,252	770 Added 34.07%	3,030 $682,000
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $479,730 - $562,062	2,260 New	2,260 $481,000
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $714,754 - $792,968	-3,060 Closed	0 $0
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $90,983 - $106,026	410 Added 15.47%	3,060 $761,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $573,407 - $682,825	2,650 New	2,650 $609,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Capital Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Planning LLC with notifications on news.